Works matching DE "RILUZOLE"

Results: 274
    1
    2
    3
    4
    5

    An Exploratory Trial of EPI-589 in Amyotrophic Lateral Sclerosis (EPIC-ALS): Protocol for a Multicenter, Open-Labeled, 24-Week, Single-Group Study.

    Published in:
    JMIR Research Protocols, 2023, v. 12, n. 1, p. 819, doi. 10.2196/42032
    By:
    • Shotaro Haji;
    • Koji Fujita;
    • Ryosuke Oki;
    • Yusuke Osaki;
    • Ryosuke Miyamoto;
    • Hiroyuki Morino;
    • Seiichi Nagano;
    • Naoki Atsuta;
    • Yuki Kanazawa;
    • Yuki Matsumoto;
    • Atsuko Arisawa;
    • Hisashi Kawai;
    • Yasutaka Sato;
    • Satoshi Sakaguchi;
    • Kenta Yagi;
    • Tatsuto Hamatani;
    • Tatsuo Kagimura;
    • Hiroaki Yanagawa;
    • Hideki Mochizuki;
    • Manabu Doyu
    Publication type:
    Article
    6
    7

    Efficacy and Safety of Zilucoplan in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial.

    Published in:
    JAMA Network Open, 2025, v. 8, n. 2, p. e2459058, doi. 10.1001/jamanetworkopen.2024.59058
    By:
    • Paganoni, Sabrina;
    • Fournier, Christina N.;
    • Macklin, Eric A.;
    • Chibnik, Lori B.;
    • Quintana, Melanie;
    • Saville, Benjamin R.;
    • Detry, Michelle A.;
    • Vestrucci, Matteo;
    • Marion, Joe;
    • McGlothlin, Anna;
    • Ajroud-Driss, Senda;
    • Chase, Marianne;
    • Pothier, Lindsay;
    • Harkey, Brittney A.;
    • Yu, Hong;
    • Sherman, Alexander V.;
    • Shefner, Jeremy M.;
    • Hall, Meghan;
    • Kittle, Gale;
    • Berry, James D.
    Publication type:
    Article
    8

    Riluzole for Degenerative Cervical Myelopathy: A Secondary Analysis of the CSM-PROTECT Trial.

    Published in:
    JAMA Network Open, 2024, v. 7, n. 6, p. e2415643, doi. 10.1001/jamanetworkopen.2024.15643
    By:
    • Fehlings, Michael G.;
    • Pedro, Karlo M.;
    • Alvi, Mohammed Ali;
    • Badhiwala, Jetan H.;
    • Ahn, Henry;
    • Farhadi, H. Francis;
    • Shaffrey, Christopher I.;
    • Nassr, Ahmad;
    • Mummaneni, Praveen;
    • Arnold, Paul M.;
    • Jacobs, W. Bradley;
    • Riew, K. Daniel;
    • Kelly, Michael;
    • Brodke, Darrel S.;
    • Vaccaro, Alexander R.;
    • Hilibrand, Alan S.;
    • Wilson, Jason;
    • Harrop, James S.;
    • Yoon, S. Tim;
    • Kim, Kee D.
    Publication type:
    Article
    9
    10
    11

    Riluzole Suppresses Growth and Enhances Response to Endocrine Therapy in ER+ Breast Cancer.

    Published in:
    Journal of the Endocrine Society, 2023, v. 7, n. 10, p. 1, doi. 10.1210/jendso/bvad117
    By:
    • Olukoya, Ayodeji O;
    • Stires, Hillary;
    • Bahnassy, Shaymaa;
    • Persaud, Sonali;
    • Guerra, Yanira;
    • Ranjit, Suman;
    • Ma, Shihong;
    • Cruz, M Idalia;
    • Benitez, Carlos;
    • Rozeboom, Aaron M;
    • Ceuleers, Hannah;
    • Berry, Deborah L;
    • Jacobsen, Britta M;
    • Raj, Ganesh V;
    • Riggins, Rebecca B
    Publication type:
    Article
    12
    13
    14
    15

    SPTLC2 variants are associated with early‐onset ALS and FTD due to aberrant sphingolipid synthesis.

    Published in:
    Annals of Clinical & Translational Neurology, 2024, v. 11, n. 4, p. 946, doi. 10.1002/acn3.52013
    By:
    • Naruse, Hiroya;
    • Ishiura, Hiroyuki;
    • Esaki, Kayoko;
    • Mitsui, Jun;
    • Satake, Wataru;
    • Greimel, Peter;
    • Shingai, Nanoka;
    • Machino, Yuka;
    • Kokubo, Yasumasa;
    • Hamaguchi, Hirotoshi;
    • Oda, Tetsuya;
    • Ikkaku, Tomoko;
    • Yokota, Ichiro;
    • Takahashi, Yuji;
    • Suzuki, Yuta;
    • Matsukawa, Takashi;
    • Goto, Jun;
    • Koh, Kishin;
    • Takiyama, Yoshihisa;
    • Morishita, Shinichi
    Publication type:
    Article
    16
    17
    18
    19

    A randomized controlled phase II trial of riluzole in early multiple sclerosis.

    Published in:
    Annals of Clinical & Translational Neurology, 2014, v. 1, n. 5, p. 340, doi. 10.1002/acn3.60
    By:
    • Waubant, Emmanuelle;
    • Maghzi, Amir‐Hadi;
    • Revirajan, Nisha;
    • Spain, Rebecca;
    • Julian, Laura;
    • Mowry, Ellen M.;
    • Marcus, Jacqueline;
    • Liu, Shuang;
    • Jin, Chengshi;
    • Green, Ari;
    • McCulloch, Charles E.;
    • Pelletier, Daniel
    Publication type:
    Article
    20

    Real-world prognostic role of riluzole use in ALS: a multi-center study from PRECISION-ALS.

    Published in:
    Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 2025, v. 26, p. 50, doi. 10.1080/21678421.2025.2472889
    By:
    • Vasta, Rosario;
    • Ombelet, Fouke;
    • Hobin, Frederik;
    • Manera, Umberto;
    • Ammar, Al-Chalabi;
    • Caravaca Puchades, Alejandro;
    • Corcia, Philippe;
    • Galvin, Miriam;
    • Hardiman, Orla;
    • Heverin, Mark;
    • Holmdahl, Oskar;
    • Ingre, Caroline;
    • Lamaire, Nikita;
    • McDermott, Christopher;
    • Mac Domhnaill, Éanna;
    • McDonough, Harry;
    • McFarlane, Robert;
    • Mouzouri, Mohammed;
    • Sarah, Opie-Martin;
    • Povedano Panadés, Mónica
    Publication type:
    Article
    21

    Characterization, epidemiology, and factors associated with evolution and survival in patients with amyotrophic lateral sclerosis in southeastern Spain, 2008–2021: a population-based study.

    Published in:
    Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 2025, v. 26, n. 3/4, p. 268, doi. 10.1080/21678421.2024.2439454
    By:
    • García-Ramírez, Yaiza;
    • Cayuela-Fuentes, Juana-María;
    • Mira-Escolano, María-Pilar;
    • Maceda-Roldán, Luis-Alberto;
    • Mikulasova, Eva;
    • Oliva-López, Cristina;
    • Sánchez-Escámez, Antonia;
    • Ciller-Montoya, Pilar;
    • Palomar-Rodríguez, Joaquín A.
    Publication type:
    Article
    22

    Correction.

    Published in:
    2024
    Publication type:
    Correction Notice
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34

    Theme 9 Therapeutic Strategies.

    Published in:
    Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 2016, v. 17, n. Sup1, p. 236, doi. 10.1080/21678421.2016.1232064
    Publication type:
    Article
    35

    Survival analysis of geospatial factors in the Irish ALS cohort.

    Published in:
    Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 2016, v. 17, n. 7/8/2016, p. 555, doi. 10.1080/21678421.2016.1179326
    By:
    • Rooney, James;
    • Heverin, Mark;
    • Vajda, Alice;
    • Burke, Tom;
    • Galvin, Miriam;
    • Tobin, Katy;
    • Elamin, Marwa;
    • Staines, Anthony;
    • Hardiman, Orla
    Publication type:
    Article
    36

    Prognostic factors and survival of ALS patients from Belgrade, Serbia.

    Published in:
    Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 2016, v. 17, n. 7/8/2016, p. 508, doi. 10.1080/21678421.2016.1195410
    By:
    • Stevic, Zorica;
    • Kostic-Dedic, Svetlana;
    • Peric, Stojan;
    • Dedic, Velimir;
    • Basta, Ivana;
    • Rakocevic-Stojanovic, Vidosava;
    • Lavrnic, Dragana
    Publication type:
    Article
    37
    38

    Amyotrophic lateral sclerosis progression: Iran-ALS clinical registry, a multicentre study.

    Published in:
    Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 2015, v. 16, n. 7/8, p. 506, doi. 10.3109/21678421.2015.1074698
    By:
    • Shamshiri, Hosein;
    • Fatehi, Farzad;
    • Davoudi, Farnoush;
    • Mir, Elham;
    • Pourmirza, Behin;
    • Abolfazli, Roya;
    • Etemadifar, Masoud;
    • Harirchian, Mohammad Hossein;
    • Gharagozli, Koroush;
    • Ayromlou, Hormoz;
    • Basiri, Keivan;
    • Zamani, Babak;
    • Rohani, Mohammad;
    • Sedighi, Behnaz;
    • Roudbari, Ali;
    • Delavar Kasmaei, Hossein;
    • Nikkhah, Karim;
    • Ranjbar Naeini, Alireza;
    • Nafissi, Shahriar
    Publication type:
    Article
    39

    Evidence of an environmental effect on survival in ALS.

    Published in:
    Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 2014, v. 15, n. 7/8, p. 528, doi. 10.3109/21678421.2014.911326
    By:
    • Keren, Noa;
    • Scott, Kirsten M.;
    • Tsuda, Miho;
    • Barnwell, Jessica;
    • Knibb, Jonathan A.;
    • Ellis, Cathy M.;
    • Leigh, P. Nigel;
    • Shaw, Christopher E.;
    • Al-Chalabi, Ammar
    Publication type:
    Article
    40

    Quality improvement in neurology: Amyotrophic Lateral Sclerosis Quality Measures.

    Published in:
    Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 2014, v. 15, n. 3/4, p. 165, doi. 10.3109/21678421.2013.875706
    By:
    • Miller, Robert G.;
    • Brooks, Benjamin Rix;
    • Swain-Eng, Rebecca J.;
    • Basner, Robert C.;
    • Carter, Gregory T.;
    • Casey, Patricia;
    • Cohen, Adam B.;
    • Dubinsky, Richard;
    • Forshew, Dallas;
    • Jackson, Carlayne E.;
    • Kasarskis, Ed;
    • Procaccini, Nicholas J.;
    • Sanjak, Mohammed;
    • Tolin, Fredrik P.
    Publication type:
    Article
    41

    Racial differences in motor neuron disease.

    Published in:
    Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 2014, v. 15, n. 1/2, p. 114, doi. 10.3109/21678421.2013.837930
    By:
    • Gundogdu, Betul;
    • Al-Lahham, Tawfiq;
    • Kadlubar, Fred;
    • Spencer, Horace;
    • Rudnicki, Stacy A.
    Publication type:
    Article
    42
    43
    44
    45
    46
    47
    48
    49

    Longitudinal Impact of Acute Spinal Cord Injury on Clinical Pharmacokinetics of Riluzole, a Potential Neuroprotective Agent.

    Published in:
    Journal of Clinical Pharmacology, 2021, v. 61, n. 9, p. 1232, doi. 10.1002/jcph.1876
    By:
    • Nguyen, Ashley;
    • Chow, Diana S‐L.;
    • Wu, Lei;
    • Teng, Yang;
    • Sarkar, Mahua;
    • Toups, Elizabeth G.;
    • Harrop, James S.;
    • Schmitt, Karl M.;
    • Johnson, Michele M.;
    • Guest, James D.;
    • Aarabi, Bizhan;
    • Shaffrey, Christopher I.;
    • Boakye, Maxwell;
    • Frankowski, Ralph F.;
    • Fehlings, Michael G.;
    • Grossman, Robert G.
    Publication type:
    Article
    50